Published

Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Drug and Alcohol Dependence
Date: 2014-06-06
Source: OpenAlex
DOI: 10.1016/j.drugalcdep.2014.02.072
PubMed: Unavailable

Authors

Matthew P. Bradstreet Matthew W. Johnson Katherine A. MacLean Roland R. Griffiths

Watch author

Topics and keywords

psilocybin General Other Psilocybin Hallucinogen TRIPS architecture Psychology Psychiatry Transport engineering Engineering Psychedelics and Drug Studies Psychotherapy Techniques and Applications Mental Health and Psychiatry

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin2014-06-06

Related papers

Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-20 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-29 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25 Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09 Psilocybin Outside the ClinicJAMA Psychiatry · 2025-11-04 Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older PatientsAmerican Journal of Geriatric Psychiatry · 2025-07-22 Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02